iCAD, Inc. (NASDAQ:ICAD) Short Interest Update

iCAD, Inc. (NASDAQ:ICAD) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 231,100 shares, a decrease of 23.1% from the February 13th total of 300,600 shares. Currently, 0.9% of the company’s stock are short sold. Based on an average daily trading volume, of 444,700 shares, the short-interest ratio is currently 0.5 days.

iCAD Trading Down 0.4 %

Shares of ICAD traded down $0.01 during midday trading on Tuesday, hitting $2.32. 199,432 shares of the company’s stock traded hands, compared to its average volume of 247,663. iCAD has a 1 year low of $1.18 and a 1 year high of $3.78. The firm’s fifty day moving average is $2.63 and its 200-day moving average is $2.05. The stock has a market capitalization of $61.57 million, a price-to-earnings ratio of -17.85 and a beta of 1.95.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded iCAD from a “sell” rating to a “hold” rating in a report on Thursday, February 20th.

Institutional Trading of iCAD

Several hedge funds and other institutional investors have recently made changes to their positions in the business. Granahan Investment Management LLC purchased a new stake in shares of iCAD during the 4th quarter valued at $96,000. Integrated Wealth Concepts LLC purchased a new stake in shares of iCAD during the 4th quarter valued at $92,000. Wells Fargo & Company MN lifted its holdings in shares of iCAD by 51.3% during the 4th quarter. Wells Fargo & Company MN now owns 39,542 shares of the technology company’s stock valued at $72,000 after purchasing an additional 13,402 shares during the last quarter. Perritt Capital Management Inc increased its position in shares of iCAD by 1.9% in the 4th quarter. Perritt Capital Management Inc now owns 189,100 shares of the technology company’s stock valued at $346,000 after acquiring an additional 3,600 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of iCAD by 6.6% in the 4th quarter. Geode Capital Management LLC now owns 276,493 shares of the technology company’s stock valued at $506,000 after acquiring an additional 17,059 shares during the period. Hedge funds and other institutional investors own 24.61% of the company’s stock.

About iCAD

iCAD, Inc engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis.